Clinical trial
Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With
NCT06618872 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With
- Lead sponsor
- University Hospital, Geneva
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 3, 2024
- Completion date
- August 30, 2027
- Enrollment
- 120 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.